The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
Open accessAbstract
Fungal bloodstream infections are associated with significant patient mortality and health care costs. Nevertheless, the relationship between a delay of the initial empiric antifungal treatment until blood culture results are known and the clinical outcome is not well established. A retrospective cohort analysis with automated patient medical records and the pharmacy database at Barnes-Jewish Hospital was conducted. One hundred fifty-seven patients with a Candida bloodstream infection were identified over a 4-year period (January 2001 through December 2004). Fifty (31.8%) patients died during hospitalization. One hundred thirty-four patients had empiric antifungal treatment begun after the results of fungal cultures were known. From the time that the first blood sample for culture that was positive was drawn, 9 (5.7%) patients received antifungal treatment within 12 h, 10 (6.4%) patients received antifungal treatment between 12 and 24 h, 86 (54.8%) patients received antifungal treatment between 24 and 48 h, and 52 (33.1%) patients received antifungal treatment after 48 h. Multiple logistic regression analysis identified Acute Physiology and Chronic Health Evaluation II scores (one-point increments) (adjusted odds ratio [AOR], 1.24; 95% confidence interval [CI], 1.18 to 1.31; P < 0.001), prior antibiotic treatment (AOR, 4.05; 95% CI, 2.14 to 7.65; P = 0.028), and administration of antifungal treatment 12 h after having the first positive blood sample for culture (AOR, 2.09; 95% CI, 1.53 to 2.84; P = 0.018) as independent determinants of hospital mortality. Administration of empiric antifungal treatment 12 h after a positive blood sample for culture is drawn is common among patients with Candida bloodstream infections and is associated with greater hospital mortality. Delayed treatment of Candida bloodstream infections could be minimized by the development of more rapid diagnostic techniques for the identification of Candida bloodstream infections. Alternatively, increased use of empiric antifungal treatment in selected patients at high risk for fungal bloodstream infection could also reduce delays in treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Finally, in a study of 10,811 patients treated in four Utah hospitals, each hour delay in time from ED arrival to administration of antimicrobials was associated with 1.16 increased odds of in-hospital and 1.10 increased odds of 1-year mortality (1.13 in patients with hypotension vs 1.09 in patients without hypotension) (111).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As mentioned previously, diagnosis of invasive candidiasis and candidemia remains a great challenge, since symptoms and signs are usually non-specific, microbiological cultures are difficult to analyze, and histological specimens require invasive procedures [29,30,46].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Attributable mortality from IC remains high and increases with delays in treatment.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Blood cultures take an average of 2–3 days to grow Candida, or longer depending on the species.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measured
In the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [173]
In the citing paper
“Another single-center retrospective cohort of 157 consecutive patients with a Candida BSI showed a trend toward improved survival when appropriate antifungal therapy was administered within 12 hours of blood culture collection (mortality 11.1% vs 33.1%; P 5 .169).45”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“In multivariate analysis the odds of death was 2-fold higher if adequate therapy was delayed more than 12 hours (P 5 .018).”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“Invasive candidiasis occurs frequently in hospitalized patients, and is associated with high mortality rates due to delays in recognition and initiation of appropriate antifungals.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“There is extensive clinical evidence that delayed initiation of appropriate antifungal treatment is associated with increased mortality in patients with invasive candidiasis [70,71,72].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“Mortality rates are estimated to be as high as 45% [16], probably due to inefficient diagnostic methods and inappropriate initial antifungal therapies [17].”
From Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents (2013) · cites this paper as [17]
In the citing paper
“The Clinical and Laboratory Standards Institute (CLSI) Subcommittee for Antifungal Testing has developed standardized broth microdilution (BMD) (169) and disk diffusion (170) methods for in vitro susceptibility testing of Candida spp.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Self-citationIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Reller, L. B. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,225
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
The Risk of Determining Risk with Multivariable Models
Concato, J., Feinstein, A. R., & Holford, T. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00009 · Cited by 1,129
Cited by
Sorted by citations
Items 501–600 of 1,000
Neoh, C. F., Slavin, M. A., Chen, S. C. ‐., Stewart, K., & Kong, D. C. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.010 · Cited by 28
Epidemiology and prognosis of candidaemia in elderly patients
Ramos, A., López, N. V., Sánchez‐Romero, I., Padilla, B., Amador, P. M., Garnacho‐Montero, J., Ruíz-Camps, I., Montejo, M., Salavert, M., Mensa, J., et al. (2017) · Mycoses · doi:10.1111/myc.12677 · Cited by 29
Caspofungin: a review of its characteristics, activity, and use in intensive care units
Hashemian, S. M. R., Farhadi, T., & Velayati, A. A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1794817 · Cited by 29
García‐Effrón, G. (2021) · Journal of Fungi · doi:10.3390/jof7030197 · Cited by 30
Pierantoni, D. C., Corte, L., Casadevall, A., Robert, V., Cardinali, G., & Tascini, C. (2021) · Mycoses · doi:10.1111/myc.13291 · Cited by 29
Micafungin: an evidence-based review of its place in therapy
Reboli, A. C., & de la Torre (2014) · Core evidence · doi:10.2147/ce.s36304 · Cited by 28
Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia
Eschenauer, G. A., Nguyen, M.-H., & Clancy, C. J. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015590838 · Cited by 27
Contemporary Strategies in the Prevention and Management of Fungal Infections
Koehler, P. A., & Cornely, O. A. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.003 · Cited by 28
Essentials in Candida bloodstream infection
Mellinghoff, S. C., Cornely, O. A., & Jung, N. (2018) · Infection · doi:10.1007/s15010-018-1218-1 · Cited by 29
Emergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 29
Molecular diagnostic platforms for detectingAspergillus
Perlin, D. S., & Zhao, Y. (2008) · Medical Mycology · doi:10.1080/13693780802126583 · Cited by 27
Keane, S., Geoghegan, P., Póvoa, P. M. S. R., Nseir, S., Rodríguez, A. H., & Martín‐Loeches, I. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1528872 · Cited by 27
MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata
Bordallo-Cardona, M. Á., Agnelli, C., Gómez-Nuñez, A., Sánchez-Carrillo, C., Bouza, E., Muñoz, P., Escribano, P., & Guinea, J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01876-18 · Cited by 27
Impact of Triazole Therapeutic Drug Monitoring Availability and Timing
McCreary, E. K., Bayless, M. L., Van, A. P., Lepak, A. J., Wiebe, D. A., Schulz, L. T., & Andes, D. R. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01245-19 · Cited by 27
Wang, K., Luo, Y., Zhang, W., Xie, S., Yan, P., Liu, Y., Li, Y., Ma, X., Xiao, K., Fu, H. J., et al. (2019) · Mycoses · doi:10.1111/myc.13035 · Cited by 28
D’Ordine, R. L., Garcia, K. A., Roy, J., Zhang, Y., Markley, B., & Finkelman, M. (2020) · Medical Mycology · doi:10.1093/mmy/myaa028 · Cited by 27
Chen, T., Wagner, A. S., & Reynolds, T. B. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.842501 · Cited by 28
Alterations of serum cytokine levels and their relation with inflammatory markers in candidemia
Akın, H., Akalın, H., Budak, F., Ener, B., Ocakoğlu, G., Gürcüoğlu, E., Göral, G., & Oral, H. B. (2015) · Medical Mycology · doi:10.1093/mmy/myu084 · Cited by 28
Pharmacotherapy of yeast infections
Gómez‐López, A., Zaragoza, Ó., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.16.2801 · Cited by 29
Candidemia in the in-patient setting: treatment options and economics
Gagne, J. J., & Goldfarb, N. I. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1643 · Cited by 27
Promising immunotherapy against fungal diseases
Posch, W., Steger, M., Wilflingseder, D., & Lass‐Flörl, C. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1322576 · Cited by 28
Antifungal resistance does not necessarily affect Candida glabrata fitness
Borghi, E., Andreoni, S., Cirasola, D., Ricucci, V., Sciota, R., & Morace, G. (2014) · Journal of Chemotherapy · doi:10.1179/1973947813y.0000000100 · Cited by 25
Pini, P., Colombari, B., Marchi, E., Castagnoli, A., Venturelli, C., Sarti, M., & Blasi, E. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.07.007 · Cited by 26
Kim, J. H., Suh, J. W., & Kim, M. J. (2021) · Journal of Fungi · doi:10.3390/jof7040275 · Cited by 26
Vannini, M., Emery, S., Lieutier-Colas, F., Legueult, K., Mondain, V., Retur, N., Gastaud, L., Pomares-Estran, C., & Hasseine, L. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101210 · Cited by 27
Invasive candidiasis in Africa, what is the current picture?
Okoye, C. A., Nweze, E. I., & Ibe, C. (2022) · Pathogens and Disease · doi:10.1093/femspd/ftac012 · Cited by 26
Zaragoza, R., Pemán, J., Quindós, G., Iruretagoyena, J. R., Cuétara, M. S., Ramírez, P., Gómez, M. D., Camarena, J. J., Viudes, A., & Pontón, J. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00183-09 · Cited by 26
Invasive Candida Infections in the ICU: Diagnosis and Therapy
Hankovszky, P., Társy, D., Öveges, N., & Molnár, Z. (2015) · The Journal of Critical Care Medicine · doi:10.1515/jccm-2015-0025 · Cited by 29
Lichtenstern, C., Schmidt, J., Knaebel, H., Martin, E., Büchler, M. W., & Weigand, M. A. (2007) · Digestive Surgery · doi:10.1159/000099009 · Cited by 25
Pebotuwa, S., Kochan, K., Peleg, A. Y., Wood, B. R., & Heraud, P. (2020) · Molecules · doi:10.3390/molecules25071551 · Cited by 25
Ganguli, A., Lim, J., Mostafa, A., Saavedra, C., Rayabharam, A., Aluru, N. R., Wester, M., White, K., Kumar, J. S., McGuffin, R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209607119 · Cited by 25
Farina, C., Perin, S., Andreoni, S., Conte, M., Fazii, P., Lombardi, G., Manso, E., Morazzoni, C., & Sanna, S. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02166.x · Cited by 25
New Antimicrobial Agents for Use in the Intensive Care Unit
Ritchie, D. J., Alexander, B. T., & Finnegan, P. M. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.010 · Cited by 25
Kumar, S. N., Nisha, G. V., Sudaresan, A., Venugopal, V., Kumar, M., Lankalapalli, R. S., & Kumar, B. S. (2014) · Medical Mycology · doi:10.1093/mmy/myu012 · Cited by 25
Maheronnaghsh, M., Tolouei, S., Dehghan, P., Chadeganipour, M., & Yazdi, M. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.187394 · Cited by 25
Camp, I., Manhart, G., Schabereiter‐Gurtner, C., Spettel, K., Selitsch, B., & Willinger, B. (2020) · Infection · doi:10.1007/s15010-020-01395-7 · Cited by 25
Jekarl, D. W., Lee, S., Lee, S., Park, Y.-J., Lee, J., Baek, S. M., An, Y. J., Ock, S. M., & Lee, M. (2012) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21535 · Cited by 25
Wingard, J. R. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.11.008 · Cited by 25
Epidemiología de las candidiasis invasoras en población pediátrica y adulta
del Palacio, A., Villar, J., & Alhambra, A. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70002-6 · Cited by 24
Borman, A. M., Székely, A., Palmer, M. D., & Johnson, E. M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00913-12 · Cited by 24
Fungal Infections in COVID-19 Intensive Care Patients
Coşkun, A. S., & DURMAZ, Ş. Ö. (2021) · Polish Journal of Microbiology · doi:10.33073/pjm-2021-039 · Cited by 26
Fisher, B. T., Boge, C. L. K., Xiao, R., Shuster, S., Chin‐Quee, D. S., Allen, J. E., Shaheen, S. K., Hayden, R. T., Suganda, S., Zaoutis, T. E., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab928 · Cited by 24
Candidaemia in a paediatric centre and importance of central venous catheter removal
Öncel, E. K., Kara, A., Özsürekçi, Y., Arıkan-Akdağlı, S., Cengiz, A. B., Ceyhan, M., Gür, D., Çelik, M., & Parlakay, A. Ö. (2015) · Mycoses · doi:10.1111/myc.12288 · Cited by 24
An improved rapid quantitative detection and identification method for a wide range of fungi
Soeta, N., Terashima, M., Gotoh, M., Mori, S., Nishiyama, K., Ishioka, K., Kaneko, H., & Suzutani, T. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.006858-0 · Cited by 24
Kovanda, L. L., Maher, R., & Hope, W. W. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1185361 · Cited by 24
Shao, B., Ma, Y., Li, Q., Wang, Y., Zhu, Z., Zhao, H., Sun, J., Dong, L., Zhu, Y., Zhao, N., et al. (2016) · Xenobiotica · doi:10.1080/00498254.2016.1271960 · Cited by 24
Vázquez, J. A., & Sobel, J. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_11 · Cited by 26
Invasive candidiasis in the ICU: evidence based and on the edge of evidence
Hollenbach, E. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01571.x · Cited by 24
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Avolio, M., Grosso, S., Bruschetta, G., Rosa, R. D., & Camporese, A. (2009) · PubMed · Cited by 24
Candidainfections in the intensive care unit: epidemiology, risk factors and therapeutic strategies
Bassetti, M., Righi, E., Tumbarello, M., Biagio, A. D., Rosso, R., & Viscoli, C. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.5.875 · Cited by 24
Fungemia in non-HIV-infected patients: a five-year review
Anunnatsiri, S., Chetchotisakd, P., & Mootsikapun, P. (2008) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.04.009 · Cited by 25
Darouiche, R. O. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.013 · Cited by 23
Nucleic-Acid-Based Molecular Fungal Diagnostics: A Way to a Better Future
Gudisa, R., Harchand, R., & Rudramurthy, S. M. (2024) · Diagnostics · doi:10.3390/diagnostics14050520 · Cited by 24
Poissy, J., Rouzé, A., Cornu, M., Nseir, S., & Sendid, B. (2022) · Journal of Fungi · doi:10.3390/jof8090946 · Cited by 23
Fungemias en hospitales de la Ciudad de Buenos Aires, Argentina
Moral, L. L., Tiraboschi, I. N., Schijman, M., Bianchi, M., Guelfand, L. I., & Cataldi, S. (2011) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2011.11.001 · Cited by 23
Comparison of Risk Factors for Candidemia Versus Bacteremia in Hospitalized Patients
Amrutkar, P., Rege, M., Chen, H., LaRocco, M., Gentry, L. O., & Garey, K. W. (2006) · Infection · doi:10.1007/s15010-006-5677-4 · Cited by 22
Evolving role of early antifungals in the adult intensive care unit
Lam, S. W., Eschenauer, G. A., & Carver, P. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819dec9b · Cited by 23
Monitoring infection: From blood culture to polymerase chain reaction (PCR)
Book, M., Lehmann, L. E., Zhang, X., & Stüber, F. (2013) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2013.06.010 · Cited by 23
Declining Incidence of Candidemia in a Tertiary Inpatient Pediatric Population
Ota, K. V., & McGowan, K. L. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06346-11 · Cited by 23
Treatment of critically ill patients with candidemia
Mensa, J., Pitart, C., & Marco, F. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70007-4 · Cited by 23
Shorr, A. F., Wu, C., & Kothari, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq446 · Cited by 23
Jabeen, K., Kumar, H., Farooqi, J. Q., Mehboob, R., Brandt, M. E., & Zafar, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02432-15 · Cited by 23
The evolution of resistant Candida species in cancer centers
Riddell, J., & Kauffman, C. A. (2008) · Cancer · doi:10.1002/cncr.23465 · Cited by 23
SB-224289 Antagonizes the Antifungal Mechanism of the Marine Depsipeptide Papuamide A
Cassilly, C. D., Maddox, M. M., Cherian, P., Bowling, J. J., Hamann, M. T., Lee, R. E., Jr., & Reynolds, T. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154932 · Cited by 24
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?
Vázquez, J. A., Whitaker, L., & Zubovskaia, A. (2025) · Journal of Fungi · doi:10.3390/jof11040258 · Cited by 26
Role of phosphatidylserine synthase in shaping the phospholipidome of Candida albicans
Cassilly, C. D., Farmer, A. T., Montedonico, A. E., Smith, T., Campagna, S. R., & Reynolds, T. B. (2017) · FEMS Yeast Research · doi:10.1093/femsyr/fox007 · Cited by 22
Han, Q., Wang, N., Pan, C., Wang, Y., & Sang, J. (2019) · Molecular Microbiology · doi:10.1111/mmi.14335 · Cited by 22
Sganga, G., Wang, M., Capparella, M. R., Tawadrous, M., Yan, J. L., Aram, J. A., & Montravers, P. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03617-9 · Cited by 23
Díez, A., Carrano, G., Bregón-Villahoz, M., Cuétara, M. S., García‐Ruiz, J. C., Fernandez-de-Larrinoa, Í., & Moragues, M. D. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115509 · Cited by 22
Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients
Glöckner, A., & Karthaus, M. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01885.x · Cited by 23
Morace, G., Borghi, E., Iatta, R., Amato, G., Andreoni, S., Brigante, G., Farina, C., Cascio, G. L., Lombardi, G., Manso, E., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-130 · Cited by 22
Lunel, F. M. V., Donnelly, J. P., van der Lee, H. A. L., Blijlevens, N. M. A., & Verweij, P. E. (2011) · Medical Mycology · doi:10.3109/13693786.2011.582889 · Cited by 22
Ylipalosaari, P., Ala-Kokko, T. I., Karhu, J., Koskela, M., Laurila, J., Ohtonen, P. P., & Syrjälä, H. (2012) · Critical Care · doi:10.1186/cc11307 · Cited by 23
Girmenia, C., Aversa, F., Busca, A., Candoni, A., Cesaro, S., Luppi, M., Pagano, L., Rossi, G., Venditti, A., & Nosari, A. (2012) · Hematological Oncology · doi:10.1002/hon.2031 · Cited by 22
Using sweeping-micellar electrokinetic chromatography to determine voriconazole in patient plasma
Lin, S.-C., Lin, S., Chen, J., & Kuo, C. (2010) · Talanta · doi:10.1016/j.talanta.2010.05.027 · Cited by 22
Alothman, A. F., Althaqafi, A. O., Matar, M. J., Moghnieh, R., Alenazi, T. H., Farahat, F. M., Corman, S. L., Solem, C. T., Raghubir, N., Macahilig, C. P., et al. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s97413 · Cited by 22
Treatment of invasive candidiasis with echinocandins
Glöckner, A., Steinbach, A., Vehreschild, J. J., & Cornely, O. A. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01645.x · Cited by 22
Schroeder, J. A., Wilson, C. M., & Pappas, P. G. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.11.007 · Cited by 26
Anidulafungin for the treatment of invasive candidiasis
Mayr, A., Aigner, M., & Lass‐Flörl, C. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03448.x · Cited by 21
Serum 1,3-βD-Glucan Assay in the Diagnosis of Invasive Fungal Disease in Neonates
Mackay, C. A., Ballot, D. E., & Perovic, O. (2011) · Pediatric Reports · doi:10.4081/pr.2011.e14 · Cited by 22
Pallerla, S. R., Dong, D. V., Linh, L. T. K., Son, T. V., Quyen, D. T., Hoan, P. Q., Trung, N. T., The, N. T., Rüter, J., Boutin, S., et al. (2022) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-022-00530-6 · Cited by 21
Laakso, S., Kirveskari, J., Tissari, P., & Mäki, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026655 · Cited by 21
on behalf of the IDEA study investigators, Maschmeyer, G., Heinz, W., Hertenstein, B., Horst, H. A., Requadt, C., Wagner, T., Cornely, O. A., Löffler, J., & Ruhnke, M. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1794-4 · Cited by 21
Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes
Ruan, S., Huang, Y., Chu, C.-C., Yu, C., & Hsueh, P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.02.021 · Cited by 21
Montagna, M. T., Lovero, G., Coretti, C., Giglio, O. D., Martinelli, D., Bedini, A., Delia, M., Rosato, A., Codeluppi, M., & Caggiano, G. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.075507-0 · Cited by 22
Graus, M. S., Neumann, A. K., & Timlin, J. A. (2017) · Journal of Biomedical Optics · doi:10.1117/1.jbo.22.1.016002 · Cited by 20
Dupont, H., Mahjoub, Y., Chouaki, T., Lorne, E., & Zogheib, E. H. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002698 · Cited by 21
Impact of an antifungal stewardship intervention on optimization of candidemia management
Winders, H. R., Wagner, J. L., King, S. T., Barber, K. E., & Stover, K. R. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117745267 · Cited by 21
Beyda, N. D., Amadio, J., Rodriguez, J. R., Malinowski, K., Garey, K. W., Wanger, A. R., & Ostrosky‐Zeichner, L. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00471-18 · Cited by 21
Nieto, M., Robles, J. C., Causse, M., Gutiérrez, L., Perez, M. C., Ferrer, R., Xercavins, M., Herrero, E., Sirvent, E., Fernández, C., et al. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-0248-z · Cited by 22
Wu, J., Xie, S., Zhang, G., Zhan, J., Xie, W., Yu, R., Xue, B., Cen, Y., Chai, J., Chen, H., et al. (2014) · Burns & Trauma · doi:10.4103/2321-3868.130182 · Cited by 20
Recent advances in the treatment of life-threatening, invasive fungal infections
Drew, R. H., Townsend, M. L., Pound, M. W., Johnson, S. W., & Perfect, J. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.838217 · Cited by 22
Kumar, A., & Kethireddy, S. (2010) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(09)79335-9 · Cited by 21
Typing of Candida isolates from patients with invasive infection and concomitant colonization
Brillowska‐Dąbrowska, A., Bergmann, O. J., Jensen, I. M., Jarløv, J. O., & Arendrup, M. C. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903348336 · Cited by 21
Charles, P. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202435.98240.ed · Cited by 21
Yeoh, S. F., Lee, T. J., Chew, K. L., Lin, S., Yeo, D., & Setia, S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s165676 · Cited by 20
Mallick, D. C., Kaushik, N., Goyal, L., Mallick, L., & Singh, P. K. (2025) · Diseases · doi:10.3390/diseases13040093 · Cited by 29
Yan, T., Li, S., Ou, H., Zhu, S., Huang, L., & Wang, D. (2020) · World Journal of Surgery · doi:10.1007/s00268-020-05380-x · Cited by 21
Yoo, J., Kim, S., Hur, S., Ha, J., Huh, K., & Cha, W. C. (2021) · JMIR Medical Informatics · doi:10.2196/24651 · Cited by 20
Lim, D. H., Jee, H., Moon, K., Lim, C. S., & Jang, W. S. (2022) · Pathogens · doi:10.3390/pathogens11020111 · Cited by 20
Metadata
- Authors
- Morrell, M., Fraser, V. J., & Kollef, M. H.
- Affiliations
- Washington University in St. Louis (US)
- Pulmonary and Critical Care Division
- Corresponding author
- Kollef, Marin H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-09
- Volume
- 49
- Issue
- 9
- Pages
- 3640-3645
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1195428
- OpenAlex
- W2137575148
- Cited by
- 1,286
- References
- 47
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 41 · 2023: 33 · 2022: 53 · 2021: 51 · 2020: 58 · 2019: 63 · 2018: 65 · 2017: 67 · 2016: 71 · 2015: 77 · 2014: 97 · 2013: 75 · 2012: 78
- FWCI
- 27.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- candidemia, fungemia, empirical antifungal therapy, treatment delay, blood culture, in-hospital mortality, APACHE II score, prior antibiotic use, rapid diagnostic tests
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candidiasis, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Cohort Studies, Logistic Models, Fungemia, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
